Tests a support team helping adults with type 2 diabetes use glucose monitors
Tests a support team helping adults with type 2 diabetes use glucose monitors.
Plain-language title generated from the registry record
Registry title: A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring
Key facts
- Where
- Worcester, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 25 and 75 years old?
Source: NCT05911256, who can take part
Where in United States
- University of MassachusettsWorcester, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Massachusetts, Worcester
- Trial code
- NCT05911256
- Record updated
- 4 September 2026
- Original description
Continuous glucose monitoring (CGM) can help improve blood sugar management in type 2 diabetes. A sequential, multiple assignment, randomized trial will evaluate clinical pharmacists, community health workers, and telehealth in supporting CGM use to improve blood sugar control.Read full original descriptionShow less
TEAM Support to Improve Glycemic Control Using CGM in Diverse Populations
Continuous glucose monitoring (CGM) can help improve blood sugar management in type 2 diabetes. A sequential, multiple assignment, randomized trial will evaluate clinical pharmacists, community health workers, and telehealth in supporting CGM use to improve blood sugar control.
Inclusion: Age 25-75; History of T2DM > 1 year; Speak English or Spanish; A1c ≥ 8% (within past 6 months) - with reduction if necessary based on recruitment; eGFR (estimated glomerular filtration rate) > 30; Willingness to use continuous glucose monitoring (CGM) and work with a community health worker (including home visits) and clinical pharmacist.
Exclusion: Plans for weight reduction surgery or prescription weight loss medication (specific for weight loss, not GLP-1); Current use of steroids; Abuse of illicit drugs; Specific comorbidities (e.g., recent MI, TIA, CVA, malignancy, hemoglobinopathy, severe hypoglycemia, etc.); Psychiatric disorder that may limit ability to perform study tasks; Skin changes that preclude use of sensor or allergy to adhesive; Current, recent, or planned use of CGM; Pregnancy (or planned pregnancy); Planning to leave geographic area within 12 months or distance from clinical site > 20 miles; Participation in another study.